{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:44:08Z","timestamp":1779115448429,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.canrad.2021.10.001","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T19:39:49Z","timestamp":1640201989000},"page":"323-328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Radiotherapy for penile cancers"],"prefix":"10.1016","volume":"26","author":[{"given":"A.","family":"Escande","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Peiffert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Dejean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-M.","family":"Hannoun-L\u00e9vi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Cordoba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Pommier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Haie-M\u00e9der","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Chargari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2021.10.001_bib0135","doi-asserted-by":"crossref","first-page":"R133","DOI":"10.1016\/j.purol.2019.01.008","article-title":"French ccAFU guidelines\u00a0\u2013\u00a0Update 2018\u20132020: penile cancer","volume":"28","author":"Savoie","year":"2018","journal-title":"Prog Urol"},{"key":"10.1016\/j.canrad.2021.10.001_bib0140","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eururo.2014.10.017","article-title":"EAU guidelines on penile cancer 2014 update","volume":"67","author":"Hakenberg","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.canrad.2021.10.001_bib0145","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11547-008-0273-6","article-title":"Local staging of penile cancer using magnetic resonance imaging with pharmacologically-induced penile erection","volume":"113","author":"Petralia","year":"2008","journal-title":"Radiol Med"},{"key":"10.1016\/j.canrad.2021.10.001_bib0150","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.eururo.2008.04.016","article-title":"Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients","volume":"54","author":"Leijte","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.canrad.2021.10.001_bib0155","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.juro.2011.10.149","article-title":"p16(INK4a) is a marker of good prognosis for primary invasive penile squamous cell carcinoma: a multi-institutional study","volume":"187","author":"Gunia","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2021.10.001_bib0160","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.juro.2011.10.033","article-title":"Prospective evaluation of (18F)-fluorodeoxyglucose positron emission tomography-computerized tomography to assess inguinal lymph node status in invasive squamous cell carcinoma of the penis","volume":"187","author":"Souillac","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2021.10.001_bib0165","doi-asserted-by":"crossref","first-page":"vi115","DOI":"10.1093\/annonc\/mdt286","article-title":"Penile cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Van Poppel","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2021.10.001_bib0170","first-page":"386","article-title":"Brachytherapy: An overview for clinicians","volume":"69","author":"Chargari","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.canrad.2021.10.001_bib0175","doi-asserted-by":"crossref","first-page":"855","DOI":"10.21037\/tau.2017.07.02","article-title":"Contemporary role of radiotherapy in the management of penile cancer","volume":"6","author":"Korzeniowski","year":"2017","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.canrad.2021.10.001_bib0180","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ijrobp.2017.02.090","article-title":"Brachytherapy for conservative treatment of invasive penile carcinoma: prognostic factors and long-term analysis of outcome","volume":"99","author":"Escande","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.10.001_bib0185","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.brachy.2015.03.008","article-title":"The role of brachytherapy in organ preservation for penile cancer: a meta-analysis and review of the literature","volume":"14","author":"Hasan","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.canrad.2021.10.001_bib0190","doi-asserted-by":"crossref","first-page":"100469","DOI":"10.18632\/oncotarget.18761","article-title":"Comparison of efficacy between brachytherapy and penectomy in patients with penile cancer: a meta-analysis","volume":"8","author":"Hu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canrad.2021.10.001_bib0195","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2490-9-8","article-title":"Identifying the needs of penile cancer sufferers: a systematic review of the quality of life, psychosexual and psychosocial literature in penile cancer","volume":"9","author":"Maddineni","year":"2009","journal-title":"BMC Urol"},{"key":"10.1016\/j.canrad.2021.10.001_bib0200","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.brachy.2017.09.006","article-title":"Long-term evaluation of urinary, sexual, and quality of life outcomes after brachytherapy for penile carcinoma","volume":"17","author":"Gambachidze","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.canrad.2021.10.001_bib0205","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jgo.2017.11.001","article-title":"Brachytherapy for conservative treatment of invasive penile carcinoma in older patients: Single institution experience","volume":"9","author":"Escande","year":"2018","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.canrad.2021.10.001_bib0210","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0959-8049(00)00368-3","article-title":"Radiation therapy alone or combined surgery and radiation therapy in squamous cell carcinoma of the penis?","volume":"37","author":"Zouhair","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2021.10.001_bib0215","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/j.clgc.2020.02.007","article-title":"Definitive chemoradiotherapy for locally advanced, lymph node positive, nonmetastatic penile squamous cell carcinoma","volume":"18","author":"McComas","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.canrad.2021.10.001_bib0220","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.eururo.2018.04.003","article-title":"Risks and benefits of adjuvant radiotherapy after inguinal lymphadenectomy in node positive penile cancer: a systematic review by the European Association of Urology Penile Cancer Guidelines Panel","volume":"74","author":"Robinson","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.canrad.2021.10.001_bib0225","article-title":"Is there a benefit to adjuvant radiation in stage III penile cancer after lymph node dissection?","volume":"36","author":"Winters","year":"2018","journal-title":"Findings from the National Cancer Database. Urol Oncol"},{"key":"10.1016\/j.canrad.2021.10.001_bib0230","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.euf.2019.05.010","article-title":"The International Penile Advanced Cancer Trial (InPACT): rationale and current status","volume":"5","author":"Canter","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.canrad.2021.10.001_bib0235","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.brachy.2013.01.167","article-title":"American Brachytherapy Society\u2013Groupe europ\u00e9en de curieth\u00e9rapie\u2013European Society of Therapeutic Radiation Oncology (ABS-GEC-ESTRO) consensus statement for penile brachytherapy","volume":"12","author":"Crook","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.canrad.2021.10.001_bib0240","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.clon.2015.03.010","article-title":"Clinical experience with pulse dose rate brachytherapy for conservative treatment of penile carcinoma and comparison with historical data of low dose rate brachytherapy","volume":"27","author":"Kamsu-Kom","year":"2015","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.canrad.2021.10.001_bib0245","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1748-717X-9-142","article-title":"High dose rate brachytherapy in localized penile cancer: short-term clinical outcome analysis","volume":"9","author":"Rouscoff","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2021.10.001_bib0250","article-title":"Organ preserving radiation strategies for penile cancer","author":"Crook","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.canrad.2021.10.001_bib0255","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brachy.2019.12.003","article-title":"High dose rate brachytherapy for localized penile cancer: evolution of a technique","volume":"19","author":"Marban","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.canrad.2021.10.001_bib0260","doi-asserted-by":"crossref","first-page":"S643","DOI":"10.1016\/S0167-8140(21)01239-1","article-title":"PO-1221: dose\u2013volume predictors of distal urethral toxicity after PDR brachytherapy for penile carcinoma","volume":"152","author":"Achkar","year":"2020","journal-title":"Radiother Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321821002614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321821002614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:38:02Z","timestamp":1761136682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321821002614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":26,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1278321821002614"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2021.10.001","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy for penile cancers","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2021.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO).","name":"copyright","label":"Copyright"}]}}